States are pushing back against attempts by drug companies to roll back a discount program “safety net” health providers use to care for vulnerable, low-income Americans. The 340B Drug Pricing Program lets some hospitals and clinics, mostly in rural, working-class communities, buy outpatient drugs at discounted prices from pharmaceutical manufacturers who participate in Medicaid and […]